Jane Street
PLYX

Jane Street’s Polaryx Therapeutics Inc PLYX Stock Holding History

Jane Street’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.6K Buy
+31,441
New +$123K ﹤0.01% 10693

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jane Street's PLYX Position: Q2 2026 in Review

Jane Street opened a new position in Polaryx Therapeutics Inc (PLYX) in Q2 2026: 31,441 shares worth $83.6K. The stake represents ﹤0.01% of the portfolio and ranks #10693 among its holdings.

13 funds tracked by Wall St. Rank hold PLYX as of Q2 2026.

  • Jane Street held 31,441 shares of Polaryx Therapeutics Inc worth $83.6K as of Q2 2026.
  • Polaryx Therapeutics Inc was a new Jane Street position in Q2 2026.
  • Polaryx Therapeutics Inc made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10693 holding.
  • 13 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.